AzTrials
AzTrials

StrokeNCT02615132

TeleRehab for Stroke Patients Using Mobile Technology

A study testing iPad in people with Stroke, run by Ottawa Hospital Research Institute at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Post-stroke communication deficits (PSCD) are a common symptom of patients having sustained a stroke. These deficits include difficulty to produce or understand language, motor speech disorders and cognitive-communication disorders. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke
What is being tested?
iPad
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteCanada
Study dates
Dec 2015to Jun 2017
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with diagnosis of stroke being discharged from the Neurology unit and/or the Neurology Acute Care Unit in the Civic Campus of TOH.
  • Patients presenting with overall mild to moderate communication deficits, And/or
  • Patients with score ≥ 1 on the best language and/or dysarthria parameters of the National Institute of Health Stroke Score (NIHSS)
  • Stroke Patients being discharged to their HOME/PRIMARY RESIDENCE awaiting outpatient speech and language therapy services.
  • And/or
  • Patients being discharged to their HOME/PRIMARY RESIDENCE who would benefit from SLP therapy services but are unable to receive these secondary to various accessibility challenges (i.e. remote geographical location, limited service availability, transportation, unable to pay for SLP services).
  • Patients must have access to Wi-Fi connection at their HOME/PRIMARY RESIDENCE.

Who cannot join

  • 1. Patients with pre-existing speech, language disorders or cognitive disorders (such as dementia).
  • 2. Patients with severe debilitating disease(s) that, in the opinion, of the investigator will not be able to perform the required tasks of the study (ex: end-stage malignancy, ALS).
  • 3. Patients with severe comprehension deficits 4. Patients not having access to Wi-Fi connection at HOME/PRIMARY RESIDENCE. 5. Patients who will be accessing the services of a private SLP while awaiting outpatient rehab.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • The Ottawa Hospital

    Ottawa, Ontario, K1Y4E9

Other trials in Canada

About this study

Official title: TeleRehab for Patients With Post-Stroke Communication Deficits Using Mobile Technology

Post-stroke communication deficits (PSCD) are a common symptom of patients having sustained a stroke. These deficits include difficulty to produce or understand language, motor speech disorders and cognitive-communication disorders. It is estimated that approximately 40% of stroke survivors will have communication disorders post stroke.

In this randomized controlled study, the investigators' objective is to test the value of providing a mobile platform-based Speech Language Therapy (SLT) program to patients discharged from an acute care hospital with stroke and PSCD and awaiting outpatient rehab services versus standard of care treatment. The investigators will offer iPad-based SLT/standard of treatment to a convenience sample of 20 patients with post-stroke communication deficits. The primary outcome will be feasibility (recruitment rate, adherence rate, retention rate, and protocol deviations), and the secondary outcome will be improvement in PSCD.

Read the detailed description
  1. APPLICANT INFORMATION

Proposed Project Title TeleRehab for Patients with Post-Stroke Communication Deficits using Mobile Technology

Primary Investigator

Karen Mallet, M.H.Sc., M.Ed. SLP (C) Speech-Language Pathologist Champlain Regional Stroke Network and the Ottawa Hospital - Civic Campus 1053 Carling Avenue, Ottawa, ON K1Y 4E9

Co-PI: Dariush Dowlatshahi MD PhD FRCPC Assistant Professor, University of Ottawa Scientist, Ottawa Hospital Research Institute Ottawa Hospital Civic Campus C2182b 1053 Carling Ave, Ottawa, ON K1Y 4E9

Primary Research Site Ottawa Hospital Research Institute

  1. LAY SUMMARY Post-stroke communication deficits (PSCD) are a common symptom of patients having sustained a stroke. These deficits include difficulty to produce or understand language, motor speech disorders and cognitive-communication disorders. It is estimated that approximately 40% of stroke survivors will have communication disorders post stroke.

Provincially, it is known that 39.8% of mildly disabled stroke survivors were discharged home without services and 13.8% were referred to outpatient rehabilitation services in 2012/13. In the Champlain Region, the overall percentage of patients being referred to outpatient rehabilitation services was only 4.1% in 2012/13 (provincial benchmark 12.8%). Meanwhile, 27.9% of patients were admitted to inpatient rehabilitation . A one month audit at the Ottawa Hospital Civic Campus (October 2014) revealed that 3/39 (7.6%) of patients attended outpatient rehabilitation.

The Champlain Region has identified a gap in services with regards to outpatient and/or community rehabilitation services. That is, the only dedicated outpatient stroke services available in the Champlain Region are at Elizabeth Bruyère. There is the possibility of accessing general outpatient speech and language services at the Montfort Hospital, the Queensway Carleton Hospital and Perth Hospital. However, there are no outpatient services for Renfrew County or the Eastern Counties.

Community Care Access Centers (CCAC) are another source of outpatient rehabilitation. However, these services are limited and are not in keeping with Canadian Stroke Best Practice Recommendations, where it is recommended that clients should have a minimum of 45 minutes per day up to 3 hours per day, 3 to 5 days per week based on patient's needs and goals. Between 2011 and 2013, the mean number of rehabilitation visits provided in the Champlain Region for CCAC was between 3.3 and 5.2 visits [this included the following disciplines Physiotherapy (PT), Occupational therapy (OT), Speech Language Pathology (SLP) \& Social Work (SW)] .

Other than publically funded/supported services, patients could access the services of SLPs through community services such as the Aphasia Center of Ottawa (fee for service), the University of Ottawa Inter-professional Clinic (Francophones only) and private SLPs (fee for service). Unfortunately, these are either cost prohibitive or language prohibitive.

Patients being discharged home who require SLP services are sometimes placed on a waitlist to access these services. While others, are not able to access outpatient services because of a variety of reasons including: patient lives at too great a distance from the rehabilitation facility (>30 minutes); unable to access reliable transportation to and from outpatient services; or the patient does not have the stamina to participate in the demands/schedule of outpatient therapy and travel to and from outpatient service.

In this randomized controlled study, the investigators' objective is to test the value of providing a mobile platform-based Speech Language Therapy (SLT) program to patients discharged from an acute care hospital with stroke and PSCD and awaiting outpatient rehab services versus standard of care treatment. The investigators will offer iPad-based SLT/standard of treatment to a convenience sample of 20 patients with post-stroke communication deficits. The primary outcome will be feasibility (recruitment rate, adherence rate, retention rate, and protocol deviations), and the secondary outcome will be improvement in PSCD.

  1. OBJECTIVES

Research question:

Is it feasible, practical and effective to deliver SLT using mobile technology (iPad) to patients with PSCD being discharged home/primary residence from the acute care setting?

Rationale PSCD affects 15-40% of patients during the recovery phase after stroke. It limits post-stroke rehabilitation, and is associated with increased disability and mortality. While screening can identify those patients at risk of PSCD, targeted treatment is not always available. Although quality of life in patients with PSCD is difficult to measure directly, the disruption in communication with its likely effects on employment status and social networks suggests that its impact can be profound. Patients with PSCD have greater morbidity than stroke patients without PSCD. While most, if not all, patients with post-stroke PSCD have some functional recovery, residual deficits are common.

Objective 1: To test the feasibility and practicality of using mobile technology (iPad) for delivering SLT to patients with PSCD being discharged HOME/PRIMARY RESIDENCE from the acute care setting

Objective 2: To explore the efficacy of using mobile technology in delivering SLT in patients with PSCD being discharged HOME/PRIMARY RESIDENCE from the acute care setting.

  1. APPROACH

Study population: Patients being discharged HOME/PRIMARY RESIDENCE from the acute care setting at TOH and only requiring communication therapy. According to a 2013 Ottawa Hospital census, 50 patients per month are admitted to the Neurology inpatient service with a primary diagnosis of stroke. Also, an ongoing TOH research project using a similar design (iTherapist) was able to recruit approximately 3 to 5 patients per month over a 6 month period. For this study the investigators have selected a convenience sample of 20 patients over an 18 month period.

Patient identification and selection: All patients admitted to the Civic Campus' Neurology inpatient service with a diagnosis of stroke AND communication deficit (as assessed by an SLP) that are being discharged home/primary residence awaiting outpatient SLP services will be screened by research personnel for study eligibility. Patients will first be approached by clinical SLP or clinicians within the circle of care and must give permission to speak to research personnel.

Design and Methods:

This is an 18 month randomized controlled trial, recruiting post-stroke patients presenting with communication deficits.

Intervention: The intervention will consist of patients being randomly assigned to either standard of care or receiving an iPad upon being discharged home from the acute care setting. The iPad will be programmed with specific apps chosen from the following list:

  1. Tactus Therapy suite of Speech-Language therapy mobile applications, which include the following modules: Language, Category, Conversation and Questions.
  2. Speech sounds on cue for iPad by Multimedia Speech Pathology
  3. Lingraphica TalkPath Therapy
  4. Search 4 It
  5. This is to That
  6. Just Saying
  7. Get+Together
  8. RhymieStymie
  9. Morphos
  10. iVolution
  11. Blankety-Blank
  12. Chain of Thought
  13. Scrabble
  14. Fit brains
  15. Constant Therapy
  16. Boggle for iPad
  17. Pop words
  18. Anagram Twist
  19. Word explorer

The apps chosen will be specific to their communication therapy needs. These apps will be monitored remotely by an SLP. A weekly check-in with the patient will be had with an SLP using one of the following: Skype, Facetime and/or Telephone.

Patients will then be randomized to one of two groups on a 1:1 ratio:

Group I (Treatment Group): The study SLP will cater the specific regimen to individual patients based on the pattern of communication deficits. In keeping with the Canadian Stroke Best Practice Recommendations and Quality Based Procedures Handbook, the study SLP will instruct the patient to use the apps for at least one-hour per day, until they are admitted to outpatient SLP services or for a maximum of 8 weeks, whichever comes first. Throughout the telemedicine treatment phase, patients' progress will be monitored remotely by a study SLP through Apps/Skype/Facetime/Telephone consultation on a weekly basis.

Patients will also be instructed to record the amount of time they spend using the iPad in an electronic form on the device itself.

Group 2 (Control Group):

Patients will be sent home with standard of care.

Data collection All patient data will de-identified. The investigators will retain age at enrollment, sex, co-morbid medical history (vascular and neurologic conditions: MI, CAD, HTN, DM), stroke type and severity (NIHSS and MRS stroke scores). The investigators will also retain baseline and follow-up language testing results, and total usage time of the iPad.

Conditions
Stroke
Being tested
iPad
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • iPadBehavioural

    Using iPad speech therapy apps on patients with post-stroke communication deficits

Study groups in NCT02615132
Study groupRoleWhat they receive
Treatment GroupExperimentalThe study SLP will instruct the patient to use the ipad apps as intervention for at least one-hour per day, until they are admitted to outpatient SLP services or for a maximum of 8 weeks, whichever comes first. Throughout the telemedicine treatment phase, patients' progress will be monitored remotely by a study SLP through Apps/Skype/Facetime/Telephone consultation on a weekly basis.
Receives: Behavioral: iPad
ControlNo interventionPatients will be sent home with standard of care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recruitment

    The investigators will assess the primary outcome of recruitment by determining:

    Total number of patients enrolled. This is the numerical total of all patients enrolled in the study

    Measured: 13 months

Secondary outcomes (3)
  1. Retention Rate

    Attending their 8 week follow up

    Measured: 8 week follow up

  2. Adherence Rate

    Using iPad for 1 hour per day or paper and pen activities for 1 hour per day

    Measured: 8 week follow up

  3. Percentage of Patients Being Engaged in Study

    Survey addressing recruitment \& timing of intervention, iPad and apps, recovery goals and length of therapy

    Measured: 8 week follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2015 (estimated)
  2. Study startDec 2015
  3. Primary completionMay 2017
  4. Study completionJun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02615132
Sponsor's protocol ID
20150784-01H
Status last verified
May 2026
First submitted
22 Nov 2015
Last updated
6 May 2026
Data monitoring committee
No

Publications

  • Berthier ML. Poststroke aphasia : epidemiology, pathophysiology and treatment. Drugs Aging. 2005;22(2):163-82. doi: 10.2165/00002512-200522020-00006.

    PubMed 15733022
  • Nichols-Larsen DS, Clark PC, Zeringue A, Greenspan A, Blanton S. Factors influencing stroke survivors' quality of life during subacute recovery. Stroke. 2005 Jul;36(7):1480-4. doi: 10.1161/01.STR.0000170706.13595.4f. Epub 2005 Jun 9.

    PubMed 15947263

Questions about this trial

What is this clinical trial studying?

A study testing iPad in people with Stroke, run by Ottawa Hospital Research Institute at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 6 May 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recruitment (time frame: 13 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02615132, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
TeleRehab for Stroke Patients Using Mobile Technology | AzTrials